Literature DB >> 12594240

Myocardial dysfunction and male mortality in peroxisome proliferator-activated receptor alpha knockout mice overexpressing lipoprotein lipase in muscle.

Christa Nöhammer1, Friedrich Brunner, Gerald Wölkart, Philipp B Staber, Ernst Steyrer, Frank J Gonzalez, Rudolf Zechner, Gerald Hoefler.   

Abstract

Free fatty acids (FFA) are liberated from triglyceride-rich lipoproteins by lipoprotein lipase (LPL) and are considered to be a principal energy source for the heart. The peroxisome proliferator-activated receptor alpha (PPARalpha) is a key regulator of FFA catabolism. To investigate its role in cardiac muscle metabolism, transgenic mice overexpressing LPL in skeletal and cardiac muscle were bred on a PPARalpha knockout background. Fifty-five percent of male animals lacking PPARalpha and overexpressing LPL died within 4 months after birth. In contrast, females of this genotype stayed alive. Deceased animals exhibited cardiopulmonary congestion but had no increase of neutral lipids in the heart. Changes in plasma glucose, FFA, lactate, and triglycerides did not clearly account for gender-specific differences in mortality; however, they indicated a critical role for PPARalpha during fasting. Analysis of cardiac function revealed that in isolated perfused hearts, left ventricular developed pressure (a measure of contractility) was markedly lower in PPARalpha knockout mice overexpressing LPL compared with controls. Glucose uptake of isolated perfused hearts was significantly higher in PPARalpha knockout mice with both normal or increased LPL expression. However, uptake of FFA was not different among genotypes. In contrast, fasted FFA levels were significantly lower in cardiac muscle of PPARalpha knockout mice with normal LPL expression (-26%) and PPARalpha knockout mice overexpressing LPL (-38%) compared with controls. Our results indicate a critical role for PPARalpha in myocardial pump function and suggest that mouse models combining different genetic effects such as PPARalpha knockout mice overexpressing muscle LPL may be useful to study cardiomyopathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594240     DOI: 10.1097/01.lab.0000053916.61772.ca

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  14 in total

Review 1.  Sex is a potent modifier of the cardiovascular system.

Authors:  Leslie A Leinwand
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

2.  Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy.

Authors:  Barbara Gürtl; Dagmar Kratky; Christian Guelly; Lefeng Zhang; Gregor Gorkiewicz; Suman Kumar Das; Kuppusamy Palaniappan Tamilarasan; Gerald Hoefler
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

3.  Lipid metabolism and toxicity in the heart.

Authors:  Ira J Goldberg; Chad M Trent; P Christian Schulze
Journal:  Cell Metab       Date:  2012-06-06       Impact factor: 27.287

Review 4.  Sex and gender differences in myocardial hypertrophy and heart failure.

Authors:  Vera Regitz-Zagrosek; Ute Seeland
Journal:  Wien Med Wochenschr       Date:  2011-03

Review 5.  What we know and do not know about sex and cardiac disease.

Authors:  John P Konhilas
Journal:  J Biomed Biotechnol       Date:  2010-04-22

Review 6.  Lipoproteini lipase-derived fatty acids: physiology and dysfunction.

Authors:  Jee Lee; Ira J Goldberg
Journal:  Curr Hypertens Rep       Date:  2007-12       Impact factor: 5.369

Review 7.  Cardiac lipotoxicity: molecular pathways and therapeutic implications.

Authors:  Konstantinos Drosatos; P Christian Schulze
Journal:  Curr Heart Fail Rep       Date:  2013-06

8.  Ceramide is a cardiotoxin in lipotoxic cardiomyopathy.

Authors:  Tae-Sik Park; Yunying Hu; Hye-Lim Noh; Konstantinos Drosatos; Kazue Okajima; Jonathan Buchanan; Joseph Tuinei; Shunichi Homma; Xian-Cheng Jiang; E Dale Abel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2008-05-30       Impact factor: 5.922

Review 9.  Role of biological sex in normal cardiac function and in its disease outcome - a review.

Authors:  K Prabhavathi; K Tamarai Selvi; K N Poornima; A Sarvanan
Journal:  J Clin Diagn Res       Date:  2014-08-20

Review 10.  Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds.

Authors:  Fatemeh Yarmohammadi; A Wallace Hayes; Gholamreza Karimi
Journal:  Cardiovasc Toxicol       Date:  2022-01-24       Impact factor: 3.231

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.